OLIVE; Daniel
Patent Applications and Registrations
Patent applications and USPTO patent grants for OLIVE; Daniel.The latest application filed is for "novel anti-cd25 antibodies".
Company Profile
12.24.45
- OLIVE; Daniel - Marseille FR
- Olive; Daniel - Marseilles FR
Patent Activity
| Patent | Date |
|---|---|
| Novel Anti-cd25 Antibodies App 20220251232 - OLIVE; Daniel ; et al. | 2022-08-11 |
| Antibodies Having Specificity For Btn2 And Uses Thereof App 20220162305 - FOUCHER; Etienne ; et al. | 2022-05-26 |
| Anti-btn3a Antibodies And Their Use In Treating Cancer Or Infectious Disorders App 20220112289 - TRUNEH; Alemseged ; et al. | 2022-04-14 |
| Btn3a Binding Proteins And Uses Thereof App 20220073619 - TRUNEH; Alemseged ; et al. | 2022-03-10 |
| Antibodies directed against ICOS and uses thereof Grant 11,180,556 - Faget , et al. November 23, 2 | 2021-11-23 |
| Anti-cd277 Antibodies And Uses Thereof App 20200376104 - OLIVE; Daniel ; et al. | 2020-12-03 |
| Antibodies Directed Against ICOS and Uses Thereof App 20200347134 - Faget; Julien ; et al. | 2020-11-05 |
| Antibodies Having Specificity For Btn2 And Uses Thereof App 20200283519 - OLIVE; Daniel ; et al. | 2020-09-10 |
| Antibodies directed against ICOS and uses thereof Grant 10,745,482 - Faget , et al. A | 2020-08-18 |
| Anti-CD277 antibodies Grant 10,716,838 - Olive , et al. | 2020-07-21 |
| Antibodies having specificity to nectin-4 and uses thereof Grant 10,675,357 - Lopez , et al. | 2020-06-09 |
| Antibodies directed against ICOS and uses thereof Grant 10,633,446 - Faget , et al. | 2020-04-28 |
| Antibodies Directed Against ICOS and Uses Thereof App 20190352400 - Faget; Julien ; et al. | 2019-11-21 |
| Antibodies Directed Against ICOS and Uses Thereof App 20190315866 - Faget; Julien ; et al. | 2019-10-17 |
| Anti-cd277 Antibodies And Uses Thereof App 20190201513 - OLIVE; Daniel ; et al. | 2019-07-04 |
| Antibodies directed against ICOS for treating graft-versus-host disease Grant 10,273,306 - Marodon , et al. | 2019-04-30 |
| Antibodies Directed Against ICOS and Uses Thereof App 20180244780 - Faget; Julien ; et al. | 2018-08-30 |
| Antibodies Having Specificity To Nectin-4 And Uses Thereof App 20180243434 - LOPEZ; Marc ; et al. | 2018-08-30 |
| New Biomarker For Outcome In Aml Patients App 20180238888 - OLIVE; Daniel ; et al. | 2018-08-23 |
| Antagonist of the BTLA/HVEM interaction for use in therapy Grant 10,005,839 - Olive , et al. June 26, 2 | 2018-06-26 |
| BTLA Antibodies and Uses Thereof App 20180155428 - Olive; Daniel ; et al. | 2018-06-07 |
| Antibodies directed against ICOS and uses thereof Grant 9,975,950 - Faget , et al. May 22, 2 | 2018-05-22 |
| Non-invasive Imaging Of Tumor Pd-l1 Expression App 20180071413 - OLIVE; Daniel | 2018-03-15 |
| Anti-pd-l1 Immunotoxin For Use In Therapy App 20180064825 - OLIVE; Daniel | 2018-03-08 |
| BTLA antibodies and uses thereof Grant 9,896,507 - Olive , et al. February 20, 2 | 2018-02-20 |
| Icos Binding Proteins App 20180030136 - LIU; Yao-Bin ; et al. | 2018-02-01 |
| Antibodies Directed Against Icos For Treating Graft-versus-host Disease App 20170275372 - MARODON; Gilles ; et al. | 2017-09-28 |
| Antibodies Directed Against ICOS and Uses Thereof App 20170233478 - Faget; Julien ; et al. | 2017-08-17 |
| Antibodies directed against ICOS for treating graft-versus-host disease Grant 9,695,247 - Marodon , et al. July 4, 2 | 2017-07-04 |
| Antibodies directed against ICOS and uses thereof Grant 9,676,852 - Faget , et al. June 13, 2 | 2017-06-13 |
| PD-1 antibodies and PD-L1 antibodies and uses thereof Grant 9,637,546 - Olive , et al. May 2, 2 | 2017-05-02 |
| New Biomarker For Outcome In Aml Patients App 20170102389 - OLIVE; Daniel ; et al. | 2017-04-13 |
| Novel Antigen Peptide And Uses Thereof App 20160331818 - LOPEZ; Marc ; et al. | 2016-11-17 |
| Antibodies Directed Against ICOS and Uses Thereof App 20160264666 - Faget; Julien ; et al. | 2016-09-15 |
| Antibodies directed against ICOS and uses thereof Grant 9,376,493 - Faget , et al. June 28, 2 | 2016-06-28 |
| Combination Of A Ligand Of Hvem And An Immunotoxin For Use In Therapy App 20160151489 - OLIVE; Daniel ; et al. | 2016-06-02 |
| Antagonist Of The Btla/hvem Interaction For Use In Therapy App 20160122434 - Olive; Daniel ; et al. | 2016-05-05 |
| Antagonist Of The Btla/hvem Interaction For Use In Therapy App 20160090420 - Olive; Daniel ; et al. | 2016-03-31 |
| Antigen peptide and uses thereof Grant 9,266,922 - Lopez , et al. February 23, 2 | 2016-02-23 |
| Method for treating and diagnosing hematologic malignancies Grant 9,243,052 - Olive , et al. January 26, 2 | 2016-01-26 |
| Anti-cd277 Antibodies And Uses Thereof App 20150353643 - OLIVE; Daniel ; et al. | 2015-12-10 |
| Antibodies Directed Against Icos For Treating Graft-versus-host Disease App 20150239978 - Marodon; Gilles ; et al. | 2015-08-27 |
| BTLA Antibodies and Uses Thereof App 20150147344 - Olive; Daniel | 2015-05-28 |
| PD-1 Antibodies and PD-L1 Antibodies and Uses Thereof App 20140335093 - Olive; Daniel | 2014-11-13 |
| Anti-cd277 Antibodies And Uses Thereof App 20140322235 - Olive; Daniel ; et al. | 2014-10-30 |
| Novel Antigen Peptide And Uses Thereof App 20140178394 - Lopez; Marc ; et al. | 2014-06-26 |
| PD-1 antibodies and PD-L1 antibodies and uses thereof Grant 8,741,295 - Olive June 3, 2 | 2014-06-03 |
| Antibodies Directed Against ICOS and Uses Thereof App 20140086923 - Faget; Julien ; et al. | 2014-03-27 |
| Ligands of HVEM for treating hematologic malignancies Grant 8,318,166 - Olive , et al. November 27, 2 | 2012-11-27 |
| BTLA Antibodies and Uses Thereof App 20120064096 - Olive; Daniel | 2012-03-15 |
| PD-1 Antibodies and PD-L1 Antibodies and Uses Thereof App 20120039906 - Olive; Daniel | 2012-02-16 |
| Method for Treating and Diagnosing Hematologic Malignancies App 20110177088 - Olive; Daniel ; et al. | 2011-07-21 |
| Ligands Of Hvem For Treating Hematologic Malignancies And Autoimmune Diseases App 20100196386 - Olive; Daniel ; et al. | 2010-08-05 |
| Anti-CD28 antibody Grant 7,723,482 - Soulillou , et al. May 25, 2 | 2010-05-25 |
| Anti-Cd28 Antibody App 20080038273 - Soulillou; Jean-Paul ; et al. | 2008-02-14 |
| CDR-H1-derived peptide CB11, pharmaceutical compositions made therefrom and methods of treating disorders in mammals App 20030113322 - Bes, Cedric ; et al. | 2003-06-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 